J Clin Gastroenterol. 2012 Apr;46(4):346-7.

Soluble urokinase plasminogen activator receptor in chronic hepatitis due to hepatitis C virus.

Filik L.

Comment on

J Clin Gastroenterol. 2012 Apr;46(4):334-8.

PMID:: 22186743; [PubMed - in process]

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B. [Thromb Res. 2009]
Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
Zhou H, Wu X, Lu X, Chen G, Ye X, Huang J. Thromb Res. 2009; 123(3):537-42. Epub 2008 Aug 8.
[The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B]. [Zhonghua Gan Zang Bing Za Zhi....]
[The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR, Wang Q, Shi SS, Lu MH, Guo WD. Zhonghua Gan Zang Bing Za Zhi. 2004 Feb; 12(2):82-4.
Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells. [Acta Obstet Gynecol Scand. 2002]
Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells.
Guan YM, Carlberg M, Bruse C, Carlström K, Bergqvist A. Acta Obstet Gynecol Scand. 2002 May; 81(5):389-97.
Review Targeting urokinase-type plasminogen activator and its receptor for cancer therapy. [Anticancer Drugs. 2006]
Review Targeting urokinase-type plasminogen activator and its receptor for cancer therapy.
Nozaki S, Endo Y, Nakahara H, Yoshizawa K, Ohara T, Yamamoto E. Anticancer Drugs. 2006 Nov; 17(10):1109-17.
Review Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. [Stem Cells. 1997]
Review Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T, Behrendt N, Ploug M. Stem Cells. 1997; 15(6):398-408.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Soluble urokinase plasminogen activator receptor in chronic hepatitis due to hep...
Soluble urokinase plasminogen activator receptor in chronic hepatitis due to hepatitis C virus.
J Clin Gastroenterol. 2012 Apr ;46(4):346-7.

PubMed
A complex choreography of cell movements shapes the vertebrate eye.
A complex choreography of cell movements shapes the vertebrate eye.
Development. 2012 Jan ;139(2):359-72.

PubMed
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposi...
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
Ann Oncol. 2011 Dec 19. [Epub ahead of print]

PubMed
Dementia: what to do.
Dementia: what to do.
South Med J. 1990 Oct ;83(10):1182-9.

PubMed
Combination of extrinsic and intrinsic pathways significantly accelerates axial ...
Combination of extrinsic and intrinsic pathways significantly accelerates axial vascularization of bioartificial tissues.
Plast Reconstr Surg. 2012 Jan ;129(1):55e-65e.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Soluble urokinase plasminogen activator receptor in chronic hepatitis due to hepatitis C virus.

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information